18q Loss of Heterozygosity in Colorectal Cancer and Its Relationship with CIMP
Author Information
Author(s): Ogino Shuji, Kawasaki Takako, Kirkner Gregory J, Ohnishi Mutsuko, Fuchs Charles S
Primary Institution: Dana-Farber Cancer Institute
Hypothesis
What is the relationship between 18q loss of heterozygosity and the CpG island methylator phenotype in colorectal cancer?
Conclusion
18q loss of heterozygosity is positively correlated with CIMP-0 and inversely correlated with CIMP-low and CIMP-high in colorectal cancer.
Supporting Evidence
- CIMP-0 was significantly more common in 18q LOH-positive tumors than in LOH-negative tumors.
- CIMP-low/high was significantly more common in 18q LOH-negative tumors.
- The relationship between 18q LOH and CIMP status persisted after stratification by various clinical factors.
Takeaway
This study found that tumors with a specific genetic change (18q LOH) are more likely to have no methylation in certain genes, which is important for understanding colorectal cancer.
Methodology
The study used MethyLight technology to quantify DNA methylation in 8 CIMP-specific promoters in 758 non-MSI-high colorectal cancers from two large cohorts.
Limitations
The study excluded MSI-H tumors and relied on strict criteria for defining 18q LOH, which may limit generalizability.
Participant Demographics
The study included participants from the Nurses' Health Study and the Health Professionals Follow-up Study, with a total of 920 colorectal cancer cases initially included.
Statistical Information
P-Value
0.002
Statistical Significance
p = 0.002
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website